Hemogenomics Private Limited

Provides blood transfusion services and ID-NAT testing to prevent spread of HIV and hepatitis.

2002 | Bangalore, Karnataka (India) | Active
Last Updated:

Hemogenomics Profile

Key Indicators

  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 2.23 Cr
  • Company Age 23 Year, 3 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 40.00 Cr
  • Revenue Growth 44.71%
  • Profit Growth 131.56%
  • Ebitda 169.06%
  • Net Worth 12.82%
  • Total Assets -4.07%

About Hemogenomics

Hemogenomics Private Limited (HPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 January 2002 and has a history of 23 years and three months. Its registered office is in Bangalore, Karnataka, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.23 Cr.

The company currently has active open charges totaling ₹40.00 Cr.

Anurag Bagaria, William Rutter, and Sumit Bagaria serve as directors at the Company.

Company Details

  • Location

    Bangalore, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U73100KA2002PTC030032

  • Company No.

    030032

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    22 Jan 2002

  • Date of AGM

    27 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Healthcare

What products or services does Hemogenomics Private Limited offer?

Hemogenomics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.

Company report

Hemogenomics Private Limited

Explore comprehensive data for Hemogenomics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Hemogenomics?

Executive Team (1)

NameDesignationAppointment DateStatus
Sumit Bagaria Country flag representing In Managing Director18-Jan-2011Current

Board Members (2)

NameDesignationAppointment DateStatus
William Rutter Country flag representing Us Director 25-Nov-2002Current
Anurag Bagaria Country flag representing In Director 08-Mar-2010Current

Financial Performance of Hemogenomics.

Hemogenomics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.71% increase. The company also saw a substantial improvement in profitability, with a 131.56% increase in profit. The company's net worth Soared by an impressive increase of 12.82%.

Hemogenomics revenue growth over time
Hemogenomics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
44.71%
Revenue from Operations
45.53%
Total Assets
-4.07%
Profit or Loss
131.56%
Net Worth
12.82%
EBITDA
169.06%

What is the Ownership and Shareholding Structure of Hemogenomics?

In 2023, Hemogenomics had a promoter holding of 65.02% and a public holding of 34.99%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹40.00 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Citi Bank N.A. : 40.00 Cr

Latest Charge Details

DateLenderAmountStatus
02 Mar 2016Citi Bank N.A.₹5.00 CrOpen
11 Jan 2012Citi Bank N.A.₹35.00 CrOpen

How Many Employees Work at Hemogenomics?

Hemogenomics has a workforce of 99 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Hemogenomics Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemogenomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemogenomics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Hemogenomics

Recent activity within the organization

  • Annual General Meeting

    Hemogenomics Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Hemogenomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.

  • Charges

    A charge with Citi Bank N.A. of Rs. 35.00 Cr registered on 11 Jan 2012 with Charge ID 10337103 was modified on 15 Feb 2022.

  • Charges

    A charge with Citi Bank N.A. amounted to Rs. 5.00 Cr with Charge ID 100019339 was registered on 02 Mar 2016.

  • Charges

    A charge with Citi Bank N.A. amounted to Rs. 35.00 Cr with Charge ID 10337103 was registered on 11 Jan 2012.

  • Director Appointment

    Sumit Bagaria was appointed as a Managing Director was appointed as a Managing Director on 18 Jan 2011 & has been associated with this company since 14 years 3 months .

Frequently asked questions

  • What is the Incorporation or founding date of Hemogenomics Private Limited?

    Hemogenomics Private Limited was incorporated on 22 Jan 2002.

  • What is authorized share capital and paid-up capital of Hemogenomics Private Limited?

    The authorized share capital of Hemogenomics Private Limited is ₹ 4.00 Cr and paid-up capital is ₹ 2.23 Cr.

  • Who are the current board members & directors of Hemogenomics Private Limited?

    Currently 3 directors are associated with Hemogenomics Private Limited.

    • Anurag Bagaria
    • William J Rutter
    • Sumit Bagaria

  • What is the registered address of Hemogenomics Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Hemogenomics Private Limited is Kemwell HouseNo.11 Tumkur Road, Bangalore., Karnataka, India, 560022.

  • What is the corporate identification number (CIN) and company number of Hemogenomics Private Limited?

    The corporate identification number (CIN) of Hemogenomics Private Limited is U73100KA2002PTC030032 and the company number is 030032 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Hemogenomics Private Limited?

    The Official website of Hemogenomics Private Limited is https://www.hemogenomics.com

  • What has been the recent revenue trend for Hemogenomics Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Hemogenomics Private Limited has risen by 44.71%.

  • How many employees does Hemogenomics Private Limited currently have?

    As Per 2023 financial reports, 99 employees are currently employed by Hemogenomics Private Limited.

  • What change has been observed in the net worth of Hemogenomics Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Hemogenomics Private Limited has experienced an upsurge of 12.82%.

  • What are the total open charges for Hemogenomics Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Hemogenomics Private Limited amount to ₹ 40.00 Cr.

  • When was the last Balance Sheet of Hemogenomics Private Limited filed with the ROC?

    The most recent Balance Sheet for Hemogenomics Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Diagnostic Centers & Pathology Labs